FDA Drug Safety Podcasts Provide Emerging Safety Information
Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) provides FDA Drug Safety Podcasts to present emerging safety information about drugs in conjunction with the release of Public Health Advisories and other drug safety issues. Recent Drug Safety Podcasts present information on the new boxed warning and contraindication for AdcetrisTM (brentuximab vedotin), an update on preliminary findings from ongoing investigations of CardioGen-82®, and information about the addition of another concentration of liquid acetaminophen marketed for infants.